Literature DB >> 23944907

Challenges in estimation of glycated hemoglobin in India.

Ranjit Unnikrishnan1, Viswanathan Mohan.   

Abstract

Glycated hemoglobin (HbA1c) is the most widely accepted index of long-term glycemic control. However, there are some clinical situations that make the accurate measurement of HbA1c difficult. Although some of these situations are general, others are more specific to some parts of the world like India. These conditions include hemoglobinopathies such as thalassemias and structural hemoglobin (Hb) variants such as HbS and HbD, as well as iron-deficiency anemia and the use of certain drugs. Because of the relatively frequent occurrence of some of these conditions in some parts of India, it is important that they are looked for when evaluating an inappropriately high or low HbA1c level. Alternative indices may have to be used for assessing glycemic control in these cases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23944907      PMCID: PMC3781113          DOI: 10.1089/dia.2013.0144

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  11 in total

Review 1.  Review of hemoglobin A(1c) in the management of diabetes.

Authors:  Emily Jane Gallagher; Derek Le Roith; Zachary Bloomgarden
Journal:  J Diabetes       Date:  2009-01-27       Impact factor: 4.006

Review 2.  A review of variant hemoglobins interfering with hemoglobin A1c measurement.

Authors:  Randie R Little; William L Roberts
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

3.  International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 17.152

4.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

5.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

6.  Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study.

Authors:  D Mohanty; R B Colah; A C Gorakshakar; R Z Patel; D C Master; J Mahanta; S K Sharma; U Chaudhari; M Ghosh; S Das; R P Britt; S Singh; C Ross; L Jagannathan; R Kaul; D K Shukla; V Muthuswamy
Journal:  J Community Genet       Date:  2012-10-21

7.  Global epidemiology of hemoglobin disorders.

Authors:  M Angastiniotis; B Modell
Journal:  Ann N Y Acad Sci       Date:  1998-06-30       Impact factor: 5.691

8.  Spuriously high prevalence of prediabetes diagnosed by HbA(1c) in young indians partly explained by hematological factors and iron deficiency anemia.

Authors:  Pallavi S Hardikar; Suyog M Joshi; Dattatray S Bhat; Deepa A Raut; Prachi A Katre; Himangi G Lubree; Abhay Jere; Anand N Pandit; Caroline H D Fall; Chittaranjan S Yajnik
Journal:  Diabetes Care       Date:  2012-02-08       Impact factor: 19.112

9.  Drugs affecting HbA1c levels.

Authors:  Ranjit Unnikrishnan; Ranjit Mohan Anjana; Viswanathan Mohan
Journal:  Indian J Endocrinol Metab       Date:  2012-07

10.  Artifactually lowered glycosylated hemoglobin (HbA1c %) in patient with diabetes on dapsone.

Authors:  Amit Rastogi; Ankur Gahlot; N K Agrawal; S K Singh
Journal:  Indian J Endocrinol Metab       Date:  2012-07
View more
  5 in total

1.  Isolated HbA1c identifies a different subgroup of individuals with type 2 diabetes compared to fasting or post-challenge glucose in Asian Indians: The CARRS and MASALA studies.

Authors:  U P Gujral; D Prabhakaran; R Pradeepa; N R Kandula; D Kondal; M Deepa; N A Zakai; R M Anjana; G Rautela; V Mohan; K M V Narayan; N Tandon; A M Kanaya
Journal:  Diabetes Res Clin Pract       Date:  2019-05-28       Impact factor: 5.602

2.  Glucose patterns during the OGTT and risk of future diabetes in an urban Indian population: The CARRS study.

Authors:  Adam Hulman; Unjali P Gujral; K M Venkat Narayan; Rajendra Pradeepa; Deepa Mohan; Ranjit Mohan Anjana; Viswanathan Mohan; Kristine Færch; Daniel R Witte
Journal:  Diabetes Res Clin Pract       Date:  2017-02-17       Impact factor: 5.602

3.  Trends in Laboratory Testing Practice for Diabetes Mellitus.

Authors:  Mithu Banerjee; Samuel Vasikaran
Journal:  EJIFCC       Date:  2020-09-29

4.  Impact of Anemia and Red Cell Indices on the Diagnosis of Pre-Diabetes and Diabetes in Indian Adult Population: Is there a Cut-off Guide for Clinicians?

Authors:  Subramanian Kannan; Chinthala Jaipalreddy; Vellaichamy Muthupandi Annapandian; Bangalore Venkatraman Murali Mohan; Sharat Damodar; Kranti Shreesh Khadilkar; Kumbenahalli Siddegowda Shivaprasad
Journal:  Indian J Endocrinol Metab       Date:  2019 Jan-Feb

5.  Clinical profile, outcomes, and progression to type 2 diabetes among Indian women with gestational diabetes mellitus seen at a diabetes center in south India.

Authors:  Manni Mohanraj Mahalakshmi; Balaji Bhavadharini; Maheswari Kumar; Ranjit Mohan Anjana; Sapna S Shah; Akila Bridgette; Mridusmita Choudhury; Margaret Henderson; Lane Desborough; Mohan Viswanathan; Harish Ranjani
Journal:  Indian J Endocrinol Metab       Date:  2014-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.